RNF43

RNF43 Overview

English NameE3 ubiquitin-protein ligase RNF43Approved Drugs0
Drugs in Clinical Trials1Target Synonym
Highest Development StagePhase 1 Clinical
English NameE3 ubiquitin-protein ligase RNF43
Target Synonym
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 1 Clinical

RNF43 Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    Fc Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
RN3-H5256
Human
HEK293
Human RNF43 Protein, Fc Tag (MALS verified)
Total: 1
  • 1

RNF43 Background

E3 ubiquitin-protein ligase that acts as a negative regulator of the Wnt signaling pathway by mediating the ubiquitination, endocytosis and subsequent degradation of Wnt receptor complex components Frizzled. Acts on both canonical and non-canonical Wnt signaling pathway. Along with RSPO2 and ZNRF3, constitutes a master switch that governs limb specification (By similarity)

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
SZN-043SZN-043; SWEETS-1Phase 1 ClinicalSurrozen IncHepatitis, Alcoholic; Liver Cirrhosis
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland